10-Q Filing

REGENXBIO INC. CIK: 1590877 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001564590-17-009868`
Period End Date	20170331
Filing Date	20170509
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	rgnx-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 37 Cash Flow Statement 56 Comprehensive Income 1

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$82.05M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$35.51M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$63.76M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$64.71M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$228.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$1.03M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.84M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.77M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$922.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.48M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.01M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.24M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$93.37M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.48M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$148.80M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.24M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$63.74M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$69.41M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.06M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.32M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$225.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$225.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$400.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$297.00K	USD	Point-in-time
Total assets	`Assets`	$224.13M	USD	Point-in-time
Total assets	`Assets`	$172.73M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.54M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.13M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$8.13M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$5.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.67M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.96M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.27M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.33M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.99M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.23M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2017 and December 31, 2016; 30,244 and 26,477 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2017 and December 31, 2016; 30,244 and 26,477 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$276.35M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$350.05M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-33.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-572.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-136.58M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-114.59M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$212.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$161.74M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$172.73M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$224.13M	USD	Point-in-time

Income Statement 37 line items

Line Item	Tag	Value	Unit	Period
License revenue	`LicensesRevenue`	$455.00K	USD	1 Quarter
License revenue	`LicensesRevenue`	$328.00K	USD	1 Quarter
Reagent sales	`OtherSalesRevenueNet`	$59.00K	USD	1 Quarter
Grant revenue	`GrantsRevenueExpenses`	$6.00K	USD	1 Quarter
Total revenues	`Revenues`	$393.00K	USD	1 Quarter
Total revenues	`Revenues`	$455.00K	USD	1 Quarter
Licensing costs	`LicenseCosts`	$66.00K	USD	1 Quarter
Licensing costs	`LicenseCosts`	$91.00K	USD	1 Quarter
Costs of reagent sales	`CostOfGoodsSold`	$30.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$6.18M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$16.62M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.62M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.48M	USD	1 Quarter
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$114.00K	USD	1 Quarter
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$-45.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$23.38M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$11.64M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-11.25M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-22.92M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$929.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$483.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$929.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$483.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.99M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.77M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net of reclassifications of $480 for the three months ended March 31, 2017	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$994.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net of reclassifications of $480 for the three months ended March 31, 2017	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-539.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$994.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-539.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-22.53M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-9.77M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-21.99M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.77M	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.82	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	1 Quarter
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.33M	shares	1 Quarter
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.67M	shares	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-21.99M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.77M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$2.59M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.55M	USD	1 Quarter
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-471.00K	USD	1 Quarter
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-469.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$48.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$554.00K	USD	1 Quarter
Realized gains on sales of marketable securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$480.00K	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-41.00K	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$13.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-803.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-113.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$68.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$169.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$449.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-88.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-10.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$55.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-182.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$2.47M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-1.92M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.21M	USD	1 Quarter
Advance payments	`IncreaseDecreaseInCustomerAdvances`	$-92.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$-44.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$453.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-17.48M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.89M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$20.43M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$5.19M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$10.50M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$10.11M	USD	1 Quarter
Sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$780.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.93M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$416.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$3.16M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-10.74M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$21.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$161.00K	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$147.00K	USD	1 Quarter
Proceeds from public offering of common stock, net of underwriting discounts and commissions	`ProceedsFromIssuanceOfCommonStock`	$71.30M	USD	1 Quarter
Issuance costs for public offering of common stock	`PaymentsOfStockIssuanceCosts`	$84.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$21.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$71.52M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-18.61M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$57.20M	USD	1 Quarter
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$82.05M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$35.51M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$82.05M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$35.51M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
Purchases of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$422.00K	USD	1 Quarter
Issuance costs for public offering of common stock in accounts payable and accrued expenses	`DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction`	$328.00K	USD	1 Quarter

Comprehensive Income 1 line items

Line Item	Tag	Value	Unit	Period
Unrealized gain (loss) on available-for-sale securities, net of reclassifications	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$480.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.